A service of StreetInsider.com
Ticker Symbol

Most Popular

AAPL 519.01
GOOG 556.54
MSFT 40.40
BAC 16.13
FB 59.72

Recently Added

STLY 2.70
GUID 9.44
ICFI 39.29
NCIT 9.91
CUB 48.64

Gaining Speed

GOLD 79.01
ABX 18.32
GLOG 28.12
GG 23.81
ISRG 415.13

ZIOPHARM Oncology (ZIOP) Reports Palifosfamide Hits PFS Events in Phase 3

ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) announced today that the Phase 3 (PICASSO 3) trial of palifosfamide (ZIO-201) in first-line metastatic soft tissue sarcoma has reached its target number of progression-free survival (PFS) events. PICASSO 3 is an international, randomized, double-blind, placebo-controlled trial whose primary endpoint is PFS....

Read More

Get Alerted When News Hits On This Stock - FREE!